Key facts
- 5Metis’s last known valuation is $30.0M (Apr 2024).
- It has raised $15.8M across 4 recorded rounds; the latest was Seed Round ($250K) in May 2025.
- Notable investors include Gates Foundation, ARCH Venture Partners, Ospraie Ag Science(farming), 1855 Capital Partners, F3 Tech Biomanufacturing Facility & Accelerator — 6 tracked in total.
- 5Metis has filed 4 Form Ds with the SEC since 2021, most recently May 2025 ($250K sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for 5Metis
Funding rounds
4 roundsAbout 5Metis
Operator of an agricultural company intended to deliver novel modes of action not currently found in the agrichemical industry. The company combines boron-based small molecule discovery and synthetic biology to discover new modes of action, enabling farmers to avail of the service to boost crop protection and crop health.
- Sector
- Materials and Resources
- HQ
- Durham, NC, United States
- Founded
- 2021
- Employees
- 13
- Website
- 5metis.com/
- Ownership
- Privately Held (backing)
5Metis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 5Metis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 5Metis in its N-PORT filings yet. We sweep new filings monthly.